Chemoembolization, Therapeutic clinical trials at UCSD
1 research study open to eligible people
open to eligible people ages 21 years and up
The primary objective of this trial is to evaluate the sensitivity and specificity of 2D and 4D contrast enhanced ultrasound for monitoring transarterial chemoembolization (TACE) response 1-2 weeks and 1 month post treatment as an alternative to contrast-enhanced magnetic resonance (MRI) or computed tomography (CT) imaging
La Jolla, California and other locations
Our lead scientists for Chemoembolization, Therapeutic research studies include Yuko Kono, MD, PhD.